Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field

Ito,Tomoyasu; Nagahara,Akihito; Osada,Taro; Kato,Junko; Ueyama,Hiroya; Saito,Hiroaki; Taniki,Nobuhito; Kanazawa,Ryo; Shimizu,Ryo; Sai,Jinkan; Shiina,Shuichiro; Watanabe,Sumio

doi:10.3892/br.2015.464

July-2015 Volume 3 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2015 Volume 3 Issue 4

Full Size Image

Article Open Access

Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field

Authors:
- Tomoyasu Ito
- Akihito Nagahara
- Taro Osada
- Junko Kato
- Hiroya Ueyama
- Hiroaki Saito
- Nobuhito Taniki
- Ryo Kanazawa
- Ryo Shimizu
- Jinkan Sai
- Shuichiro Shiina
- Sumio Watanabe
View Affiliations / Copyright

Affiliations: Department of Gastroenterology, School of Medicine, Juntendo University, Tokyo 113‑8421, Japan, Department of Gastroenterology, Juntendo University Shizuoka Hospital, Shizuoka 410‑2295, Japan

Copyright: © Ito et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 457-460
|
Published online on: May 13, 2015

https://doi.org/10.3892/br.2015.464
Expand metrics +

Abstract

Recombinant human soluble thrombomodulin (rTM) was approved recently and has been used for treatment of disseminated intravascular coagulation (DIC). The aim of the present study was to evaluate the efficacy of rTM for DIC. The data of 53 inpatients with sepsis‑induced DIC were retrospectively analyzed. Patients were classified into the rTM treatment group (n=25) and conventional treatment group (rTM not used) was the control group (n=28). Diagnosis of DIC was made according to the criteria for acute DIC of the Japan Association of Acute Medicine. Platelet count, prothrombin time‑international normalized ratio, levels of fibrin/fibrinogen degradation products (FDP), C‑reactive protein and DIC scores were measured on days 0, 3 and 7. Furthermore, the DIC resolution rate was assessed on days 3 and 7. Prior to treatment, DIC scores were 5.0±1.0 in the rTM group and 5.9±1.3 in the control group (P<0.05). Significant intra‑group improvements were observed in all the parameters, except for FDP in the two groups. Significant improvements were observed in the DIC scores in the rTM group (Δ2.0±1.9 vs. Δ1.5±1.9, P=0.001). Therefore, the results suggest that rTM would be a useful medicine for treatment of DIC in the gastroenterology field.

View Figures

View References

1	Levi M and Ten Cate H: Disseminated intravascular coagulation. N Engl J Med. 341:586–592. 1999. View Article : Google Scholar : PubMed/NCBI
2	Levi M and van der Poll T: Inflammation and coagulation. Crit Care Med. 38:(Suppl 2). S26–S34. 2010. View Article : Google Scholar : PubMed/NCBI
3	Esmon CT: The interactions between inflammation and coagulation. Br J Haematol. 131:417–430. 2005. View Article : Google Scholar : PubMed/NCBI
4	Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL and Opal SM: KyberSept investigators: Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 4:90–97. 2006. View Article : Google Scholar : PubMed/NCBI
5	Wada H, Asakura H, Okamoto K, Iba T, Uchiyama T, Kawasugi K, Koga S, Mayumi T, Koike K, Gando S, et al: Japanese Society of Thrombosis Hemostasis/DIC subcommittee: Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res. 125:6–11. 2010. View Article : Google Scholar : PubMed/NCBI
6	Dhainaut JF, Yan SB, Joyce DE, Pettilä V, Basson B, Brandt JT, Sundin DP and Levi M: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost. 2:1924–1933. 2004. View Article : Google Scholar : PubMed/NCBI
7	Nagato M, Okamoto K, Abe Y, Higure A and Yamaguchi K: Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Crit Care Med. 37:2181–2186. 2009. View Article : Google Scholar : PubMed/NCBI
8	Iba T, Nakarai E, Takayama T, Nakajima K, Sasaoka T and Ohno Y: Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care. 13:R2032009. View Article : Google Scholar : PubMed/NCBI
9	Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, et al: Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost. 5:31–41. 2007. View Article : Google Scholar : PubMed/NCBI
10	Umeki S, Adachi M, Watanabe M, Yaji S and Soejima R: Gabexate as a therapy for disseminated intravascular coagulation. Arch Intern Med. 148:1409–1412. 1988. View Article : Google Scholar : PubMed/NCBI
11	Nishiyama T, Matsukawa T and Hanaoka K: Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation? Crit Care Med. 28:1419–1422. 2000. View Article : Google Scholar : PubMed/NCBI
12	Takazono T, Nakamura S, Imamura Y, Yoshioka S, Miyazaki T, Izumikawa K, Sawai T, Matsuo N, Yanagihara K, Suyama N, et al: A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients. J Infect Chemother. 20:484–488. 2014. View Article : Google Scholar : PubMed/NCBI
13	Shimada H, Nakagawara G, Kobayashi M, Tsuchiya S, Kudo T and Morita S: Pathogenesis and clinical features of acute cholangitis accompanied by shock. Jpn J Surg. 14:269–277. 1984. View Article : Google Scholar : PubMed/NCBI
14	Shimada H, Nihmoto S, Matsuba A and Nakagawara G: Acute cholangitis: A histopathologic study. J Clin Gastroenterol. 10:197–200. 1988. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles